annual CFO:
-$331.21M+$174.06M(+34.45%)Summary
- As of today (August 18, 2025), ASND annual cash flow from operations is -$331.21 million, with the most recent change of +$174.06 million (+34.45%) on December 31, 2024.
- During the last 3 years, ASND annual CFO has risen by +$162.44 million (+32.91%).
- ASND annual CFO is now -4053.67% below its all-time high of $8.38 million, reached on December 31, 2013.
Performance
ASND Cash from operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFO:
-$8.48M+$6.59M(+43.73%)Summary
- As of today (August 18, 2025), ASND quarterly cash flow from operations is -$8.48 million, with the most recent change of +$6.59 million (+43.73%) on June 1, 2025.
- Over the past year, ASND quarterly CFO has increased by +$57.21 million (+87.09%).
- ASND quarterly CFO is now -159.71% below its all-time high of $14.20 million, reached on September 1, 2013.
Performance
ASND quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFO:
-$180.62M+$57.21M(+24.05%)Summary
- As of today (August 18, 2025), ASND TTM cash flow from operations is -$180.62 million, with the most recent change of +$57.21 million (+24.05%) on June 1, 2025.
- Over the past year, ASND TTM CFO has increased by +$172.01 million (+48.78%).
- ASND TTM CFO is now -1372.22% below its all-time high of $14.20 million, reached on September 1, 2013.
Performance
ASND TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
ASND Cash from operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +34.5% | +87.1% | +48.8% |
| 3 y3 years | +32.9% | +93.6% | +66.3% |
| 5 y5 years | -68.2% | +86.4% | +29.8% |
ASND Cash from operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +36.4% | at high | +94.9% | at high | +70.0% |
| 5 y | 5-year | -68.2% | +36.4% | at high | +94.9% | at high | +70.0% |
| alltime | all time | -4053.7% | +36.4% | -159.7% | +94.9% | -1372.2% | +70.0% |
ASND Cash from operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$8.48M(-43.7%) | -$180.62M(-24.1%) |
| Mar 2025 | - | -$15.06M(-84.3%) | -$237.82M(-28.6%) |
| Dec 2024 | -$331.21M(-34.4%) | -$95.72M(+56.0%) | -$333.01M(+20.2%) |
| Sep 2024 | - | -$61.36M(-6.6%) | -$276.98M(-21.5%) |
| Jun 2024 | - | -$65.68M(-40.4%) | -$352.63M(-22.4%) |
| Mar 2024 | - | -$110.25M(+177.8%) | -$454.42M(-9.5%) |
| Dec 2023 | -$505.27M(-3.0%) | -$39.69M(-71.0%) | -$501.94M(-16.7%) |
| Sep 2023 | - | -$137.00M(-18.2%) | -$602.42M(+7.0%) |
| Jun 2023 | - | -$167.47M(+6.2%) | -$562.81M(+6.6%) |
| Mar 2023 | - | -$157.77M(+12.6%) | -$528.13M(+2.1%) |
| Dec 2022 | -$520.97M(+5.5%) | -$140.17M(+43.9%) | -$517.08M(-0.3%) |
| Sep 2022 | - | -$97.40M(-26.7%) | -$518.68M(-3.4%) |
| Jun 2022 | - | -$132.79M(-9.5%) | -$536.67M(-1.1%) |
| Mar 2022 | - | -$146.72M(+3.5%) | -$542.60M(+9.8%) |
| Dec 2021 | -$493.65M(+59.5%) | -$141.77M(+22.9%) | -$494.19M(+7.8%) |
| Sep 2021 | - | -$115.39M(-16.8%) | -$458.60M(+11.7%) |
| Jun 2021 | - | -$138.71M(+41.1%) | -$410.66M(+22.8%) |
| Mar 2021 | - | -$98.31M(-7.4%) | -$334.29M(+8.0%) |
| Dec 2020 | -$309.56M(+57.2%) | -$106.18M(+57.4%) | -$309.56M(+20.1%) |
| Sep 2020 | - | -$67.46M(+8.2%) | -$257.79M(+0.1%) |
| Jun 2020 | - | -$62.34M(-15.3%) | -$257.44M(+28.0%) |
| Mar 2020 | - | -$73.58M(+35.2%) | -$201.08M(+2.1%) |
| Dec 2019 | -$196.92M | -$54.41M(-18.9%) | -$196.92M(+7.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2019 | - | -$67.10M(+1021.1%) | -$183.86M(+7.5%) |
| Jun 2019 | - | -$5.99M(-91.4%) | -$171.11M(-9.3%) |
| Mar 2019 | - | -$69.41M(+67.8%) | -$188.72M(+14.8%) |
| Dec 2018 | -$163.75M(+52.7%) | -$41.36M(-23.9%) | -$164.46M(+7.8%) |
| Sep 2018 | - | -$54.35M(+130.3%) | -$152.50M(+19.3%) |
| Jun 2018 | - | -$23.60M(-47.7%) | -$127.87M(-1.6%) |
| Mar 2018 | - | -$45.15M(+53.6%) | -$129.93M(+21.1%) |
| Dec 2017 | -$107.27M(+61.1%) | -$29.39M(-1.1%) | -$107.33M(+11.1%) |
| Sep 2017 | - | -$29.72M(+15.8%) | -$96.60M(+14.8%) |
| Jun 2017 | - | -$25.66M(+13.8%) | -$84.17M(+15.1%) |
| Mar 2017 | - | -$22.55M(+20.8%) | -$73.16M(+9.2%) |
| Dec 2016 | -$66.57M(+38.1%) | -$18.67M(+8.0%) | -$67.00M(+12.6%) |
| Sep 2016 | - | -$17.29M(+18.1%) | -$59.50M(+41.0%) |
| Jun 2016 | - | -$14.64M(-10.7%) | -$42.21M(+53.1%) |
| Mar 2016 | - | -$16.40M(+46.9%) | -$27.57M(+146.9%) |
| Dec 2015 | -$48.20M(+97.5%) | -$11.17M(+13.6%) | -$11.17M(-54.3%) |
| Dec 2014 | -$24.41M(-391.4%) | -$9.83M(+118.5%) | -$24.41M(+33.4%) |
| Sep 2014 | - | -$4.50M(-32.0%) | -$18.30M(-4740.1%) |
| Jun 2014 | - | -$6.61M(+90.7%) | $394.40K(-94.4%) |
| Mar 2014 | - | -$3.47M(-6.8%) | $7.01M(-33.1%) |
| Dec 2013 | $8.38M(-1100.3%) | -$3.72M(-126.2%) | $10.48M(-26.2%) |
| Sep 2013 | - | $14.20M | $14.20M |
| Dec 2012 | -$837.50K | - | - |
FAQ
- What is Ascendis Pharma A/S annual cash flow from operations?
- What is the all time high annual CFO for Ascendis Pharma A/S?
- What is Ascendis Pharma A/S annual CFO year-on-year change?
- What is Ascendis Pharma A/S quarterly cash flow from operations?
- What is the all time high quarterly CFO for Ascendis Pharma A/S?
- What is Ascendis Pharma A/S quarterly CFO year-on-year change?
- What is Ascendis Pharma A/S TTM cash flow from operations?
- What is the all time high TTM CFO for Ascendis Pharma A/S?
- What is Ascendis Pharma A/S TTM CFO year-on-year change?
What is Ascendis Pharma A/S annual cash flow from operations?
The current annual CFO of ASND is -$331.21M
What is the all time high annual CFO for Ascendis Pharma A/S?
Ascendis Pharma A/S all-time high annual cash flow from operations is $8.38M
What is Ascendis Pharma A/S annual CFO year-on-year change?
Over the past year, ASND annual cash flow from operations has changed by +$174.06M (+34.45%)
What is Ascendis Pharma A/S quarterly cash flow from operations?
The current quarterly CFO of ASND is -$8.48M
What is the all time high quarterly CFO for Ascendis Pharma A/S?
Ascendis Pharma A/S all-time high quarterly cash flow from operations is $14.20M
What is Ascendis Pharma A/S quarterly CFO year-on-year change?
Over the past year, ASND quarterly cash flow from operations has changed by +$57.21M (+87.09%)
What is Ascendis Pharma A/S TTM cash flow from operations?
The current TTM CFO of ASND is -$180.62M
What is the all time high TTM CFO for Ascendis Pharma A/S?
Ascendis Pharma A/S all-time high TTM cash flow from operations is $14.20M
What is Ascendis Pharma A/S TTM CFO year-on-year change?
Over the past year, ASND TTM cash flow from operations has changed by +$172.01M (+48.78%)